Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 73 of 102, showing 5 Applications out of 510 total, starting on record 361, ending on 365

# Protocol No Study Title Investigator(s) & Site(s)

361.

ECCT/17/05/01   Multicenter Study of the Accuracy of the BD MAXâ„¢MDR-TB Assay
    Multicenter Study of the Accuracy of the BD MAX™MDR-TB Assay for Detection of M. tuberculosis Complex and Mutations Associated with Resistance to Rifampin or Isoniazid   
Principal Investigator(s)
1. SAMUEL GURRION OUMA
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITIUTE
 
View

362.

ECCT/17/04/01   Odón Device for assisted vaginal delivery
    Feasibility, safety and preliminary efficacy study of a new device (Odón  Device) for assisted vaginal delivery   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
Kenyatta National Hospital
 
View

363.

ECCT/17/03/05   HOPE Sickle Cell Disease Clinical Study
    A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease   
Principal Investigator(s)
1. Videlis Nduba
2. Jessie Nyokabi Githanga
Site(s) in Kenya
1. Gertrude\'s Children\'s Hospital (Nairobi City county)
2. Strathmore University Medical Center (Nairobi City county)
3. KEMRI CRDR Clinical Research clinic at Chandaria Health Center (Nairobi City county)
4. KEMRI Kondele Childrens Hospital Center for Clinical Research (Kisumu county)
5. KEMRI Clinical Research Center at Siaya County Referral Hospital (Siaya county)
 
View

364.

ECCT/17/03/03   FLACSAM
    First Line Antimicrobials in Children with Complicated Severe Acute Malnutrition   
Principal Investigator(s)
1. James Berkley
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
 
View

365.

ECCT/17/03/02   The Edoxaban Hokusai VTE PEDIATRICS Study
    A PHASE 3, OPEN-LABEL, RANDOMIZED, MULTICENTER, CONTROLLED TRIAL TO EVALUATE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN AND TO COMPARE THE EFFICACY AND SAFETY OF EDOXABAN WITH STANDARD OF CARE ANTICOAGULANT THERAPY IN PEDIATRIC SUBJECTS FROM BIRTH TO LESS THAN 18 YEARS OF AGE WITH CONFIRMED VENOUS THROMBOEMBOLISM (VTE)   
Principal Investigator(s)
1. Bernhards Ragama Ogutu Ragama
Site(s) in Kenya
1. Gertrudes Hospital (Nairobi City county)
2. Mater Hospital (Nairobi City county)
 
View